Evidence map›Paper›PMID 32949355›Full record

ArticleIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2020

Under-expression of microRNA-146a and 21 and their association with Crohn's disease.

Mohammad Mirzakhani, Ali Khalili, Mehdi Shahbazi, Saeid Abediankenari, Soheil Ebrahimpour, Mousa Mohammadnia-Afrouzi

Abstract read
PubMed Publisher
In one paragraph

Article in Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?International journal of molecular sciences · 2023
    Review
  5. Review
  6. Indian Journal of Gastroenterology July-August 2020.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mohammad MirzakhaniStudent Research Committee, School of Medicine, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0002-8831-3006
Ali KhaliliImmunogenetics Research Center, Mazandaran University of Medical Sciences, Sari, IR, Iran.
Mehdi ShahbaziCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Ganjafrooz Street, Babol, IR, Iran.
Saeid AbediankenariImmunogenetics Research Center, Mazandaran University of Medical Sciences, Sari, IR, Iran.
Soheil EbrahimpourInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Mousa Mohammadnia-AfrouziCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Ganjafrooz Street, Babol, IR, Iran. m.mohammadnia@mubabol.ac.ir.ORCID 0000-0003-2083-7425
Babol University of Medical Sciences · IRMazandaran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) can post-transcriptionally regulate gene expression and are involved in the immune response. Excessive immune response to the gut microbiota plays a major role in the pathogenesis of Crohn's disease (CD). Regarding the role of miRNAs in immune response, this study aimed to investigate the contribution of miRNAs in the pathogenesis of CD. A total of 53 participants, including 23 CD patients and 30 healthy controls (HCs) were enrolled in this study. miRNAs, including miR-21, miR-29a, miR-29b, miR-31, miR-146a, miR-155, miR-181a, and miR-181c were evaluated via TaqMan MicroRNA Assays. Among the eight miRNAs, the amounts of miR-146a and miR-21 were significantly decreased in the CD patients relative to HC subjects. Moreover, we showed that there was a negative correlation between miR-146a and Harvey-Bradshaw index (HBI), as well as a positive correlation of miR-21 and miR-29b with HBI. Under-expression of miR-146a and miR-21, which are critical for the regulatory function of regulatory T cells (Tregs), is remarkably associated with CD.

Indexed as

Gene ExpressionGenetic Association StudiesAdultCrohn DiseaseDown-RegulationFemaleGastrointestinal MicrobiomeHumansMaleMicroRNAsMiddle AgedT-Lymphocytes, RegulatoryMicroRNAsMIRN146 microRNA, humanMIRN21 microRNA, humanCrohn’s diseaseGut microbiotaInflammatory bowel diseaseMicroRNAMiR-146aMiR-21Regulatory T cellsT regulatory response

Identifiers

PMID32949355
OpenAlexW3087015259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.